Prospective parents can now pick embryos based on risk predictions for thousands of diseases and odds for specific traits.
Genomic testing transformed cancer care but often leaves uncertainty around treatment effectiveness. First Ascent Biomedical's Functional Precision Oncology bridges that gap by testing living tumor ...
ROCKVILLE, Md.--(BUSINESS WIRE)--LabGenomics USA has successfully acquired Integrated Molecular Diagnostics (IMD) CLIA labs, bringing the total number of its CLIA-certified labs in the U.S. to four.
Labroots is excited to announce our 14th Annual Precision Medicine: Genomics, Proteomics & Molecular Diagnostics Virtual Event Series 2026 held on May 13th, 2026! The Precision Medicine: Genomics, ...